Does Aetna Cover Weight Loss Treatment in Mississippi? A 2026 Guide

Last updated: July 11, 2026

If you have Aetna health insurance in Mississippi and you are exploring options for medically supervised weight loss treatment, you may be wondering what your plan covers, which medications are on the formulary, and how to access care through telehealth. This guide breaks down Aetna’s weight loss coverage in Mississippi for 2026, including GLP-1 medications, prior authorization requirements, and what CVS/Caremark’s recent formulary changes mean for you.

Coverage varies significantly by plan and employer. Always verify your specific benefits before scheduling an appointment.

Ready to explore weight loss treatment? Klarity Health connects you with 2,000+ licensed providers who may be able to prescribe FDA-approved weight loss medications. Check if you may qualify →

Aetna Health Plans Available in Mississippi

Aetna offers several commercial plan types to Mississippi residents, including through employer group benefits and the ACA Marketplace. Common Aetna plan types available in Mississippi may include:

• Aetna Choice POS II — a point-of-service plan with in-network and out-of-network options
• Aetna Open Choice PPO — a preferred provider organization plan with broad network access
• Aetna Value Network — narrower network, lower premium option
• ACA Marketplace plans — individual and family plans available through the federal marketplace, subject to income-based subsidies

All Aetna commercial plans in Mississippi use CVS/Caremark as their pharmacy benefit manager (PBM). This means your prescription drug coverage, including any weight loss medications, is administered through CVS/Caremark’s formulary and prior authorization process.

Does Aetna Cover Weight Loss Medications in Mississippi?

Weight loss medication coverage under Aetna commercial plans is generally treated as an optional, employer-elected benefit. This means coverage depends on whether your specific employer or plan sponsor has chosen to include weight management drugs in the benefit design. Not all Aetna plans in Mississippi include obesity pharmacotherapy coverage by default.

If your plan does include weight loss drug coverage, the benefit is typically administered through CVS/Caremark’s specialty pharmacy and weight management formulary tier. Members with plans that include this benefit may access GLP-1 medications and other FDA-approved weight loss drugs, subject to prior authorization and clinical criteria.

To confirm whether your specific plan includes weight loss drug coverage, call Aetna Member Services at 1-800-872-3862 or review your Summary of Benefits and Coverage (SBC) document.

CVS/Caremark Weight Loss Formulary for 2026 (Aetna Plans)

Below is a summary of commonly prescribed weight loss medications and their typical formulary status under CVS/Caremark-managed Aetna commercial plans in 2026. Actual tier placement and coverage may vary by plan design.

Tier placement affects your out-of-pocket cost. Higher tiers generally mean higher copays or coinsurance. Coverage may not apply if your plan has not elected to include the weight management drug benefit. Verify your specific plan benefits through your Aetna member portal or by calling 1-800-872-3862.

Important 2026 GLP-1 Formulary Update: Zepbound Returns

CVS Caremark removed Zepbound (tirzepatide) from its commercial formularies effective July 1, 2025, in a competitive exclusivity move that prioritized Wegovy as the preferred GLP-1. However, on May 28, 2026, CVS Health announced that Zepbound will be reinstated on CVS/Caremark commercial formularies effective October 1, 2026, as a preferred option alongside Wegovy.

This means:

• Through September 30, 2026: Zepbound is generally non-formulary on Aetna/CVS Caremark plans. You may pay full price out-of-pocket, or your provider may submit a formulary exception request if clinically warranted.
• From October 1, 2026: Zepbound is expected to be added back as a covered preferred GLP-1 option, with PA still required.
• Wegovy (semaglutide) remains the currently preferred, formulary-covered GLP-1 for weight management under most Aetna/CVS Caremark commercial plans through the remainder of 2026.

Additionally, CVS Caremark removed the new-to-market block on Foundayo (orforglipron) — a novel oral GLP-1 — effective June 1, 2026. Whether Foundayo is covered under your specific Aetna plan will depend on individual employer benefit elections. Ask your provider or pharmacist if this option may be appropriate for you.

A Note on Electronic Prescribing (EPCS) for Weight Loss Medications

You may have heard that Mississippi requires electronic prescribing for controlled substances (EPCS) under Miss. Code Ann. § 41-29-137. It is worth clarifying how this applies to weight loss medications:

• GLP-1 medications (Wegovy, Zepbound, Foundayo) — Not controlled substances. No EPCS requirement applies. Standard prescription process.
• Contrave, Orlistat — Not controlled substances. Standard prescription process.
• Phentermine, Qsymia — Schedule IV controlled substances under federal law. EPCS applies to Schedule II prescriptions under Mississippi regulations (§ 41-29-137 references DEA schedules). Mississippi providers at Klarity Health who prescribe Schedule IV medications like phentermine use compliant electronic prescribing workflows.

Prior Authorization Requirements for GLP-1 Weight Loss Medications

If your Aetna plan includes the weight management drug benefit and you are prescribed a GLP-1 such as Wegovy, prior authorization through CVS/Caremark is typically required. Common clinical criteria for PA approval may include:

• Body Mass Index (BMI) of 30 or higher (obesity), or BMI of 27 or higher with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or dyslipidemia
• Documentation that lifestyle modifications (diet and exercise) have been attempted
• No contraindications to the requested medication
• Prescriber attestation that the medication is medically necessary

Your Klarity Health provider can assess your eligibility, document the clinical rationale, and submit the prior authorization request on your behalf. To submit a PA through CVS/Caremark, providers typically use the CVS/Caremark online PA portal or fax to 1-800-378-0323.

For pharmacy-related questions on your Aetna plan, call CVS/Caremark at 1-800-552-8159.

Step Therapy and Non-Response Requirements

Some Aetna plans with GLP-1 coverage may require step therapy, meaning you may first need to demonstrate a clinical trial with a lower-cost weight loss medication before a GLP-1 is approved. Step therapy requirements, when applicable, typically require:

• A trial of at least one non-GLP-1 weight loss agent (such as phentermine, Contrave, or orlistat)
• Documentation of inadequate response (typically defined as less than 5% body weight loss at 12 weeks)
• Or documentation of a contraindication or intolerance to the step therapy agent

Your provider at Klarity Health can review your history and document any prior treatment experience to support your prior authorization request.

Mississippi Regulatory Context

Mississippi’s mental health parity law, Miss. Code Ann. § 83-9-353 et seq., requires that fully insured commercial health plans in Mississippi provide mental health and substance use disorder benefits at parity with medical-surgical benefits. While obesity treatment and weight loss pharmacotherapy are primarily classified as medical benefits rather than mental health benefits, providers at Klarity Health take a whole-person approach that addresses behavioral and mental health factors that often accompany obesity.

If you are enrolled in a self-funded employer plan (ERISA plan), note that Mississippi’s state insurance laws — including Miss. Code Ann. § 83-9-353 et seq. — generally do not apply to ERISA-governed plans. ERISA self-funded plan benefits are governed by federal law and the plan document itself.

For questions about insurance complaints or plan disputes in Mississippi, you may contact the Mississippi Insurance Department (MS DOI) at 1-800-562-2957.

Telehealth Weight Loss Treatment: How Klarity Health Works

Klarity Health is a telehealth platform that connects patients in Mississippi with licensed medical providers who can evaluate eligibility for weight loss treatment, including GLP-1 medications where appropriate. Everything happens online — no in-person office visit required.

Here is how the process typically works:

1. Complete an intake form — Share your health history, current medications, and weight loss goals through a simple online questionnaire.
2. Match with a licensed provider — You are connected with a licensed provider in Mississippi from Klarity’s network of 2,000+ providers.
3. Provider evaluation — Your provider reviews your intake, may request lab work, and assesses whether you may be a candidate for weight loss medication.
4. Prescription and PA support — If appropriate, your provider may prescribe a weight loss medication and can assist with prior authorization paperwork for your Aetna/CVS Caremark plan.
5. Ongoing care — Follow-up visits to monitor progress and adjust your treatment plan as needed.

Start your weight loss journey today. Klarity Health’s licensed providers in Mississippi may be able to help you access medically supervised weight loss treatment. See if you may qualify →

Frequently Asked Questions: Aetna Weight Loss Coverage in Mississippi

Does Aetna cover Wegovy in Mississippi in 2026?

Aetna commercial plans that have elected the weight management drug benefit may cover Wegovy (semaglutide) through CVS/Caremark, typically at Tier 3–4 with prior authorization required. Not all Aetna plans in Mississippi include this benefit by default. Check your plan’s Summary of Benefits or call 1-800-872-3862 to confirm.

Does Aetna cover Zepbound in Mississippi in 2026?

As of mid-2026, Zepbound (tirzepatide) is generally non-formulary on CVS/Caremark-managed Aetna plans following its removal in July 2025. However, CVS Caremark has announced that Zepbound will be reinstated on commercial formularies effective October 1, 2026. If Zepbound is medically necessary before then, your provider may request a formulary exception.

Can I get weight loss medication through telehealth with Aetna in Mississippi?

Yes, Mississippi generally allows telehealth prescribing of non-controlled and Schedule IV weight loss medications. Klarity Health providers are licensed in Mississippi and may be able to evaluate you remotely, prescribe where appropriate, and assist with prior authorization for your Aetna plan.

Does Mississippi Medicaid cover weight loss medications?

This guide covers Aetna commercial plans. Mississippi Medicaid (administered by the Mississippi Division of Medicaid) has its own formulary and eligibility rules. Klarity Health does not currently accept Medicaid. For Medicaid coverage questions, contact the Mississippi Division of Medicaid at 1-800-421-2408.

What is the difference between Wegovy and Ozempic for weight loss?

Both contain semaglutide, but they are FDA-approved for different indications. Ozempic is indicated for type 2 diabetes management, while Wegovy is specifically FDA-approved for chronic weight management. Insurers, including Aetna, may cover them under different formulary pathways. Your provider can discuss which option may be appropriate for your clinical situation.

Does Aetna require prior authorization for phentermine?

Phentermine is a Schedule IV controlled substance appetite suppressant. Under most CVS/Caremark-managed Aetna plans, generic phentermine is typically available at Tier 1–2 and may not require prior authorization. However, plan-specific requirements vary. Check your plan benefits for details.

Can a provider prescribe Qsymia through telehealth in Mississippi?

Qsymia (phentermine/topiramate ER) is a Schedule IV controlled substance. Mississippi law and DEA regulations allow telehealth prescribing of Schedule IV medications under appropriate circumstances. Klarity Health providers follow all applicable federal and state regulations.

How do I appeal a denied Aetna prior authorization for weight loss medication?

If your prior authorization is denied, you have the right to request an internal appeal with Aetna. Contact Aetna Member Services at 1-800-872-3862 to initiate the appeal process. Your provider can submit a letter of medical necessity and supporting documentation. If the internal appeal is unsuccessful, you may request an external independent review through the Mississippi Insurance Department at 1-800-562-2957.

Key Contacts

• Aetna Member Services: 1-800-872-3862
• CVS/Caremark Pharmacy (Aetna plans): 1-800-552-8159
• Mississippi Insurance Department: 1-800-562-2957
• Mississippi Division of Medicaid: 1-800-421-2408

Explore weight loss treatment options with Klarity Health. Our 2,000+ licensed providers across Mississippi and beyond offer telehealth consultations for medically supervised weight loss. Check if you may qualify →

Disclaimer: This article is for informational purposes only and does not constitute medical or insurance advice. Insurance coverage for weight loss treatment varies by plan, employer benefit elections, and individual circumstances. Coverage terms, formulary status, and prior authorization requirements may change at any time. Always verify your specific benefits by contacting Aetna at 1-800-872-3862 or reviewing your plan documents before scheduling an appointment or filling a prescription. Klarity Health is an independent telehealth platform and is not affiliated with, endorsed by, or a representative of Aetna, CVS Health, CVS/Caremark, or any of their subsidiaries.